FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents pharmaceutical composition for intratumoral injection, containing effective for treating amount of Na+ from 2.0 M to 5.5 M and effective for treating amount of Ca2+ from 250 mM to 3.0 M in water solution at room temperature. Besides disclosed is therapeutic agent for treating malignant tumour and cancer, benign tumour and designed hyperplasia by intratumoral injection, containing 5.0479 M of Na+, 250 mM of Ca2+, 890 ml of distilled water, 10 ml of “Ultravist 370”, 20 mg of epinephrine at room temperature.
EFFECT: invention provides creation of effective anticancer composition on basis of saturated ion solution of sodium and calcium ions, injection of which can be used in treating cancer and tumour in nine human organs (carcinoma and tumour of skin and subcutaneous tissue, breast cancer, prostate cancer, thyroid cancer, lung, liver, genital organ, brain and pancreas) and some other benign diseases (skin and subcutaneous growth, cystic fibrous breast change, benign prostatic hyperplasia and thyroid nodules).
6 cl, 20 ex, 20 dwg
Title | Year | Author | Number |
---|---|---|---|
SUPPRESSION OF CANCER METASTASES | 2010 |
|
RU2571502C2 |
NOVEL COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASES | 2009 |
|
RU2563833C2 |
ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS | 2009 |
|
RU2520823C2 |
METHOD OF INHIBITING MIGRATION OF CANCER CELLS | 2006 |
|
RU2404805C2 |
METHODS FOR TREATMENT OF METASTATIC CANCER TYPES, USING AXL TRAP RECEPTORS | 2018 |
|
RU2785866C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, CONTAINING IONIC COMPOUND RELATED TO METAL ION | 2019 |
|
RU2780016C1 |
THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER | 2016 |
|
RU2720984C2 |
IMMUNOGENIC ANTI-INFLAMMATORY COMPOSITIONS | 2011 |
|
RU2722357C2 |
CONTROL POINT INHIBITOR AND WHOLE-CELL MICROBACTERIA FOR USE IN TREATING ONCOLOGICAL DISEASE | 2014 |
|
RU2719934C2 |
LIPOSOME DELIVERY OF COMPOSITIONS BASED ON VITAMIN E | 2002 |
|
RU2328273C2 |
Authors
Dates
2016-10-20—Published
2012-12-04—Filed